Pihlajalinna (PIHLIS) AGM 2025 presentation summary

Strategic transformation and operational improvements

• Profitability and financial position strengthened in 2024, with systematic leadership development and successful refinancing in Q2.

• Transformation advanced through contract changes, adaptation programs, commercial actions, and pricing adjustments.

• Enhanced management of customer relationships and conversion in care chains, with systematic strengthening of service offering.

• Process improvements in customer work and billing, procurement scale benefits, and strengthened leadership principles.

Financial performance highlights

• Achieved record-high results in 2024, with revenue of €704.4 million and adjusted EBITA of €55.2 million.

• EPS rose to €1.13, and net debt/EBITDA improved to 2.9x.

• Organic revenue growth reached 7.8%, and adjusted EBITA margin increased to 7.8%.

• Board proposes a dividend per share of €0.38.

Sustainability and employee engagement

• Published first CSRD-compliant sustainability report, emphasizing high-quality, cost-effective healthcare and timely, appropriate care.

• Focus on equality, non-discrimination, strong data protection, and customer experience (NPS 87).

• Employee engagement and well-being prioritized, with eNPS rising to 9.

• 91% of surgical patients accessed care within 5 business days.